Trends in liver transplantation for hepatitis C in a country with reduced access to direct‐acting antiviral agents

Background Hepatitis C virus (HCV)‐related cirrhosis is a leading indication for liver transplantation (LT) worldwide. Access to effective HCV treatment is inequitable globally. We aimed to analyze whether the introduction of effective HCV treatment caused an impact in LT trends in a middle‐income c...

Full description

Saved in:
Bibliographic Details
Published inClinical transplantation Vol. 32; no. 4; pp. e13230 - n/a
Main Authors Dirchwolf, Melisa, Marciano, Sebastián, Giunta, Diego H., Posadas‐Martínez, Maria L., Biggins, Scott W., Ruf, Andrés E.
Format Journal Article
LanguageEnglish
Published Denmark 01.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Hepatitis C virus (HCV)‐related cirrhosis is a leading indication for liver transplantation (LT) worldwide. Access to effective HCV treatment is inequitable globally. We aimed to analyze whether the introduction of effective HCV treatment caused an impact in LT trends in a middle‐income country. Methods Cross‐sectional analysis of all adult patients who were listed/received a LT in Argentina for HCV, alcohol‐related liver disease (ALD), or autoimmune hepatitis/primary biliary cirrhosis (AIH/PBC) from 2007 to 2017. Joinpoint regression analysis was used to identify changes in the cumulative incidence rates in waiting list (WL) registration, WL mortality, and LT. Results Liver transplantation WL for HCV increased significantly between 2007 and 2014, with an annual percentage change (APC) +7.8%, P = .01, followed by a downward slope from 2014 to 2017 with an APC −9.8%, P = .1. There were no significant changes in WL mortality. LT trends remained stable. LT for HCV without MELD exception points for HCC decreased (APC −6.6%, P = .01), whereas LT for HCV with HCC exception points increased (APC +11.1, P = .01) during the study period. Conclusion Waiting list and LT for HCV without HCC decreased, whereas LT for HCV and HCC increased; this may be related to selective antiviral treatment access for patients with advanced fibrosis.
AbstractList Background Hepatitis C virus (HCV)‐related cirrhosis is a leading indication for liver transplantation (LT) worldwide. Access to effective HCV treatment is inequitable globally. We aimed to analyze whether the introduction of effective HCV treatment caused an impact in LT trends in a middle‐income country. Methods Cross‐sectional analysis of all adult patients who were listed/received a LT in Argentina for HCV, alcohol‐related liver disease (ALD), or autoimmune hepatitis/primary biliary cirrhosis (AIH/PBC) from 2007 to 2017. Joinpoint regression analysis was used to identify changes in the cumulative incidence rates in waiting list (WL) registration, WL mortality, and LT. Results Liver transplantation WL for HCV increased significantly between 2007 and 2014, with an annual percentage change (APC) +7.8%, P = .01, followed by a downward slope from 2014 to 2017 with an APC −9.8%, P = .1. There were no significant changes in WL mortality. LT trends remained stable. LT for HCV without MELD exception points for HCC decreased (APC −6.6%, P = .01), whereas LT for HCV with HCC exception points increased (APC +11.1, P = .01) during the study period. Conclusion Waiting list and LT for HCV without HCC decreased, whereas LT for HCV and HCC increased; this may be related to selective antiviral treatment access for patients with advanced fibrosis.
Abstract Background Hepatitis C virus ( HCV )‐related cirrhosis is a leading indication for liver transplantation ( LT ) worldwide. Access to effective HCV treatment is inequitable globally. We aimed to analyze whether the introduction of effective HCV treatment caused an impact in LT trends in a middle‐income country. Methods Cross‐sectional analysis of all adult patients who were listed/received a LT in Argentina for HCV , alcohol‐related liver disease ( ALD ), or autoimmune hepatitis/primary biliary cirrhosis ( AIH / PBC ) from 2007 to 2017. Joinpoint regression analysis was used to identify changes in the cumulative incidence rates in waiting list ( WL ) registration, WL mortality, and LT . Results Liver transplantation WL for HCV increased significantly between 2007 and 2014, with an annual percentage change ( APC ) +7.8%, P  = .01, followed by a downward slope from 2014 to 2017 with an APC −9.8%, P  = .1. There were no significant changes in WL mortality. LT trends remained stable. LT for HCV without MELD exception points for HCC decreased ( APC −6.6%, P  = .01), whereas LT for HCV with HCC exception points increased ( APC +11.1, P  = .01) during the study period. Conclusion Waiting list and LT for HCV without HCC decreased, whereas LT for HCV and HCC increased; this may be related to selective antiviral treatment access for patients with advanced fibrosis.
BACKGROUNDHepatitis C virus (HCV)-related cirrhosis is a leading indication for liver transplantation (LT) worldwide. Access to effective HCV treatment is inequitable globally. We aimed to analyze whether the introduction of effective HCV treatment caused an impact in LT trends in a middle-income country. METHODSCross-sectional analysis of all adult patients who were listed/received a LT in Argentina for HCV, alcohol-related liver disease (ALD), or autoimmune hepatitis/primary biliary cirrhosis (AIH/PBC) from 2007 to 2017. Joinpoint regression analysis was used to identify changes in the cumulative incidence rates in waiting list (WL) registration, WL mortality, and LT. RESULTSLiver transplantation WL for HCV increased significantly between 2007 and 2014, with an annual percentage change (APC) +7.8%, P = .01, followed by a downward slope from 2014 to 2017 with an APC -9.8%, P = .1. There were no significant changes in WL mortality. LT trends remained stable. LT for HCV without MELD exception points for HCC decreased (APC -6.6%, P = .01), whereas LT for HCV with HCC exception points increased (APC +11.1, P = .01) during the study period. CONCLUSIONWaiting list and LT for HCV without HCC decreased, whereas LT for HCV and HCC increased; this may be related to selective antiviral treatment access for patients with advanced fibrosis.
Author Biggins, Scott W.
Posadas‐Martínez, Maria L.
Marciano, Sebastián
Dirchwolf, Melisa
Giunta, Diego H.
Ruf, Andrés E.
Author_xml – sequence: 1
  givenname: Melisa
  orcidid: 0000-0002-9083-3561
  surname: Dirchwolf
  fullname: Dirchwolf, Melisa
  email: mdirchwolf@outlook.com
  organization: Hospital Privado de Rosario
– sequence: 2
  givenname: Sebastián
  surname: Marciano
  fullname: Marciano, Sebastián
  organization: Hospital Italiano
– sequence: 3
  givenname: Diego H.
  surname: Giunta
  fullname: Giunta, Diego H.
  organization: Hospital Italiano
– sequence: 4
  givenname: Maria L.
  surname: Posadas‐Martínez
  fullname: Posadas‐Martínez, Maria L.
  organization: Hospital Italiano
– sequence: 5
  givenname: Scott W.
  surname: Biggins
  fullname: Biggins, Scott W.
  organization: University of Washington
– sequence: 6
  givenname: Andrés E.
  surname: Ruf
  fullname: Ruf, Andrés E.
  organization: Fundación para la Docencia e Investigación de las Enfermedades del Hígado (FUNDIEH)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29485711$$D View this record in MEDLINE/PubMed
BookMark eNp1kMtOAjEUhhuDkYsufAHTpS6AXhhol4Z4S0hMDK4nnfYM1AwdbDsQdj6Cz-iTWATdeTbnki9fcv4uarnaAUKXlAxoqqGOfkA54-QEdSiXsk8IZS3UIZKwNI95G3VDeEvXMR1nZ6jN5EhkE0o7KM49OBOwdbiyG_A4euXCulIuqmhrh8va4yWs0xJtwNM9qLCuGxf9Dm9tXGIPptFgsNIaQsCxxsZ60PHr41PpaN0CJ5ndWK8qrBbgYjhHp6WqAlwcew-93t_Np4_92fPD0_R21tecZaTPgUhhGOeaUMIEFCrLlCyLEmhhlFJSjoURpqDESAN0wkcmM6BFkYEcGZbxHro-eNe-fm8gxHxlg4YqfQd1E3JGiBBiwiVL6M0B1b4OwUOZr71dKb_LKcn3Iecp5Pwn5MReHbVNsQLzR_6mmoDhAdjaCnb_m_Lp_OWg_Ab434sx
CitedBy_id crossref_primary_10_1016_j_aohep_2018_11_003
crossref_primary_10_1016_j_aohep_2021_100344
crossref_primary_10_2807_1560_7917_ES_2019_24_41_1900176
Cites_doi 10.1056/NEJM199603143341104
10.1111/apt.13343
10.1002/hep.28923
10.1111/liv.13310
10.4254/wjh.v9.i7.352
10.1016/j.jhep.2016.01.029
10.1097/MEG.0000000000000272
10.1186/s12916-017-0815-7
10.1002/hep.23744
10.1002/hep.26986
10.1016/j.jhep.2016.05.010
10.1002/cpt.185
10.1097/TP.0000000000000198
10.1111/acer.13013
10.1007/s10620-014-3361-6
10.1001/jama.2012.144878
10.1002/lt.23551
ContentType Journal Article
Copyright 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Copyright_xml – notice: 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1111/ctr.13230
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1399-0012
EndPage n/a
ExternalDocumentID 10_1111_ctr_13230
29485711
CTR13230
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OC
29B
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c3250-3e098d233c01028eba55a9fbfe1bdaaa9968d8db10d9de1734d5dec8b5e94d253
IEDL.DBID DR2
ISSN 0902-0063
IngestDate Sat Aug 17 00:11:02 EDT 2024
Fri Aug 23 00:58:55 EDT 2024
Sat Sep 28 08:40:45 EDT 2024
Sat Aug 24 01:09:06 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords joinpoint regression analysis
waiting list analysis
hepatitis C
direct-acting antivirals
liver transplantation
trends
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3250-3e098d233c01028eba55a9fbfe1bdaaa9968d8db10d9de1734d5dec8b5e94d253
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9083-3561
PMID 29485711
PQID 2008887392
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2008887392
crossref_primary_10_1111_ctr_13230
pubmed_primary_29485711
wiley_primary_10_1111_ctr_13230_CTR13230
PublicationCentury 2000
PublicationDate April 2018
2018-04-00
20180401
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: April 2018
PublicationDecade 2010
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
PublicationTitle Clinical transplantation
PublicationTitleAlternate Clin Transplant
PublicationYear 2018
References 2015; 27
2017; 37
2015; 60
2017; 15
2015; 42
2017; 65
2015; 98
2016; 65
2016; 64
2014; 59
2016; 40
2012; 18
2017; 152
1996; 334
2017; 9
2010; 52
2014; 98
2012; 308
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_12_1
Ahmad OB (e_1_2_8_13_1)
Goldberg D (e_1_2_8_19_1) 2017; 152
References_xml – volume: 9
  start-page: 352
  year: 2017
  end-page: 367
  article-title: Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
  publication-title: World J Hepatol
– volume: 42
  start-page: 889
  year: 2015
  end-page: 901
  article-title: Improvement of liver function parameters in advanced HCV‐associated liver cirrhosis by IFN‐free antiviral therapies
  publication-title: Aliment Pharmacol Ther
– volume: 40
  start-page: 794
  year: 2016
  end-page: 805
  article-title: Epidemiology, evolution, and long‐term survival of alcoholic cirrhosis patients submitted to liver transplantation in Southeastern Spain
  publication-title: Alcohol Clin Exp Res
– volume: 18
  start-page: 1471
  year: 2012
  end-page: 1478
  article-title: Projected future increase in aging hepatitis C virus‐infected liver transplant candidates: a potential effect of hepatocellular carcinoma
  publication-title: Liver Transpl
– volume: 98
  start-page: 394
  year: 2015
  end-page: 402
  article-title: Direct‐acting antiviral drugs for the treatment of chronic hepatitis C virus infection: interferon free is now
  publication-title: Clin Pharmacol Ther
– volume: 15
  start-page: 52
  year: 2017
  article-title: Hepatitis C‐related hepatocellular carcinoma in the era of new generation antivirals
  publication-title: BMC Med
– volume: 59
  start-page: 2188
  year: 2014
  end-page: 2195
  article-title: Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S
  publication-title: Hepatology
– volume: 334
  start-page: 693
  year: 1996
  end-page: 699
  article-title: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
  publication-title: N Engl J Med
– volume: 64
  start-page: 1224
  year: 2016
  end-page: 1231
  article-title: Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
  publication-title: J Hepatol
– volume: 37
  start-page: 130
  issue: Suppl 1
  year: 2017
  end-page: 135
  article-title: The future of liver transplantation for viral hepatitis
  publication-title: Liver Int
– volume: 152
  start-page: e1
  issue: 1090–1099
  year: 2017
  article-title: Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation
  publication-title: Gastroenterology
– volume: 98
  start-page: 241
  year: 2014
  end-page: 246
  article-title: Liver transplantation in Latin America: the state‐of‐the‐art and future trends
  publication-title: Transplantation
– volume: 308
  start-page: 2584
  year: 2012
  end-page: 2593
  article-title: Association between sustained virological response and all‐cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis
  publication-title: JAMA
– volume: 65
  start-page: 524
  year: 2016
  end-page: 531
  article-title: Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study
  publication-title: J Hepatol
– volume: 60
  start-page: 573
  year: 2015
  end-page: 581
  article-title: Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin
  publication-title: Dig Dis Sci
– volume: 65
  start-page: 804
  year: 2017
  end-page: 812
  article-title: Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy
  publication-title: Hepatology
– volume: 52
  start-page: 833
  year: 2010
  end-page: 844
  article-title: Outcome of sustained virological responders with histologically advanced chronic hepatitis C
  publication-title: Hepatology
– volume: 27
  start-page: 355
  year: 2015
  end-page: 360
  article-title: Screening for liver cancer during transplant waiting list: a multicenter study from South America
  publication-title: Eur J Gastroenterol Hepatol
– ident: e_1_2_8_21_1
  doi: 10.1056/NEJM199603143341104
– ident: e_1_2_8_18_1
  doi: 10.1111/apt.13343
– ident: e_1_2_8_14_1
– ident: e_1_2_8_11_1
– ident: e_1_2_8_8_1
  doi: 10.1002/hep.28923
– ident: e_1_2_8_2_1
  doi: 10.1111/liv.13310
– ident: e_1_2_8_3_1
  doi: 10.4254/wjh.v9.i7.352
– volume: 152
  start-page: e1
  issue: 1090
  year: 2017
  ident: e_1_2_8_19_1
  article-title: Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation
  publication-title: Gastroenterology
  contributor:
    fullname: Goldberg D
– ident: e_1_2_8_17_1
  doi: 10.1016/j.jhep.2016.01.029
– ident: e_1_2_8_12_1
  doi: 10.1097/MEG.0000000000000272
– ident: e_1_2_8_23_1
  doi: 10.1186/s12916-017-0815-7
– ident: e_1_2_8_5_1
  doi: 10.1002/hep.23744
– ident: e_1_2_8_26_1
  doi: 10.1002/hep.26986
– ident: e_1_2_8_22_1
  doi: 10.1016/j.jhep.2016.05.010
– ident: e_1_2_8_4_1
  doi: 10.1002/cpt.185
– ident: e_1_2_8_10_1
– ident: e_1_2_8_25_1
  doi: 10.1097/TP.0000000000000198
– volume-title: Age Standardization of Rates: A New Who Standard
  ident: e_1_2_8_13_1
  contributor:
    fullname: Ahmad OB
– ident: e_1_2_8_16_1
– ident: e_1_2_8_20_1
  doi: 10.1111/acer.13013
– ident: e_1_2_8_6_1
  doi: 10.1007/s10620-014-3361-6
– ident: e_1_2_8_15_1
– ident: e_1_2_8_7_1
  doi: 10.1001/jama.2012.144878
– ident: e_1_2_8_9_1
– ident: e_1_2_8_24_1
  doi: 10.1002/lt.23551
SSID ssj0016165
Score 2.2478411
Snippet Background Hepatitis C virus (HCV)‐related cirrhosis is a leading indication for liver transplantation (LT) worldwide. Access to effective HCV treatment is...
Abstract Background Hepatitis C virus ( HCV )‐related cirrhosis is a leading indication for liver transplantation ( LT ) worldwide. Access to effective HCV...
BACKGROUNDHepatitis C virus (HCV)-related cirrhosis is a leading indication for liver transplantation (LT) worldwide. Access to effective HCV treatment is...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage e13230
SubjectTerms direct‐acting antivirals
hepatitis C
joinpoint regression analysis
liver transplantation
trends
waiting list analysis
Title Trends in liver transplantation for hepatitis C in a country with reduced access to direct‐acting antiviral agents
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fctr.13230
https://www.ncbi.nlm.nih.gov/pubmed/29485711
https://search.proquest.com/docview/2008887392
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA9jJy9-4Nf8IooHLxlt06wtnmQ4hqCHscEOQkmaTIejkzY76Mk_wb_Rv8S8ZC1OEcRbD2lo-_Lyfi_9vd9D6JxLJoOQCRIZPEFCllEiOkqRSBqw64WS-RM4Gri96_RH4c2YjRvosqqFcfoQ9YEbeIbdr8HBuSi_OHmmi7ZJpSjk6yCkB4BoUEtHGSBj20gC7ZBAHF6qCgGLp75zNRb9AJireNUGnN4Guq8e1fFMntoLLdrZ6zcVx3--yyZaXwJRfOVWzhZqqHwbaUeRxdMcz4CwgbXVPp9xV6CUYwNx8aMCFraelrgLAzm2_SaKFwxnurgALVglMbedGLGeYxc1P97eoYYif8BmsilQi2eYQ11XuYNGvetht0-WfRlIRg1iIlR5SSwDSjMQpIuV4IzxZCImyheSc25SqFjGUvieTKTyI2pMLlUWC6aSUAaM7qJmPs_VPsI0UFEnCUQYSejDTkUC-ErKiMeZEl7YQmeVhdJnJ7-RVmmL-Wip_WgtdFrZLjXOAX88eK7mi9L22DS7qMGALbTnjFpPE4AuTuT7LXRhTfP7_Gl3OLAXB38feojWDLSKHcfnCDV1sVDHBr5ocWLX6Sf-f-11
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB0hOMCFRWxlNYgDl1RNHDeJxAUVUFkPqEhcUGTHLlRUKWrTA5z4BL6RL2HGbioWISFuOThWkvF43jhv3gDsSS10EArlRYgnvFBk3FN1Y7xII9ithVr4bToauLyqN2_Cs1txOwEHZS2M04cYH7iRZ9j9mhycDqQ_eXlW9KuYS3FM2KfQ3QW55dH1WDwKoYxtJEnEQ48i8UhXiHg841u_RqMfEPMrYrUh52QO7sqHdUyTx-qwUNXs5ZuO43_fZh5mR1iUHbrFswATJl-EwrFkWSdnXeJssMLKn3elq1HKGaJc9mCIiF10BqxBAyWzLSf6z4yOdVmf5GCNZtI2Y2RFj7nA-f76RmUU-T3DyTrELu4ySaVdgyW4OTluNZreqDWDl3EETR43tSTWAecZadLFRkkhZNJWbeMrLaXELCrWsVZ-TSfa-BFHq2uTxUqYJNSB4MswmfdyswqMByaqJ4EKI02t2LlKCGJpHck4M6oWVmC3NFH65BQ40jJzwY-W2o9WgZ3SeCn6B_30kLnpDQe2zSZupAgDK7DirDqeJiBpnMj3K7BvbfP7_GmjdW0v1v4-dBumm63Li_Ti9Op8HWYQacWO8rMBk0V_aDYRzRRqyy7aD9e88ZU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5EQbz4wFd9ruLBS0qTzTYJnqRafCOi4EEIu5mtFksqbXrQkz_B3-gvcWe3KT4QxFsOmyXJ7Ox8s_nmG4AdiQKDUCgvMnjCC0XGPVXX2ovQgN1aiMJv0dHA-UX96CY8uRW3Y7BX1sI4fYjRgRt5ht2vycGfsPXJybOiVzWpFDf5-kRY5wFlXgdXI-0og2RsH0niHXoUiIeyQkTjGd36NRj9QJhfAauNOM0ZuCuf1RFNHquDQlWzl28yjv98mVmYHiJRtu-WzhyM6XweCseRZe2cdYixwQorft6RrkIpZwbjsgdNNOyi3WcNGiiZbTjRe2Z0qMt6JAarkUnbipEVXebC5vvrGxVR5PfMTNYmbnGHSSrs6i_ATfPwunHkDRszeBk3kMnjupbEGHCekSJdrJUUQiYt1dK-QimlyaFijFH5NUxQ-xE3NkedxUroJMRA8EUYz7u5XgbGAx3Vk0CFEVIjdq4SAliIkYwzrWphBbZLC6VPTn8jLfMW89FS-9EqsFXaLjXeQb88ZK67g75tsmm2UQMCK7DkjDqaJiBhnMj3K7BrTfP7_Gnj-sperPx96CZMXh4007Pji9NVmDIwK3Z8nzUYL3oDvW6gTKE27JL9ABxx8EQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+liver+transplantation+for+hepatitis+C+in+a+country+with+reduced+access+to+direct-acting+antiviral+agents&rft.jtitle=Clinical+transplantation&rft.au=Dirchwolf%2C+Melisa&rft.au=Marciano%2C+Sebasti%C3%A1n&rft.au=Giunta%2C+Diego+H&rft.au=Posadas-Mart%C3%ADnez%2C+Maria+L&rft.date=2018-04-01&rft.eissn=1399-0012&rft.volume=32&rft.issue=4&rft.spage=e13230&rft_id=info:doi/10.1111%2Fctr.13230&rft_id=info%3Apmid%2F29485711&rft.externalDocID=29485711
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0902-0063&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0902-0063&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0902-0063&client=summon